In an animal model of AD, mesenchymal stem cell (MSC)-derived exosomes delivered intranasally reduced extracellular plaque, inflammation, and glial activation
This creates demand for more targeted approaches that control excessive inflammation while preserving the beneficial aspects of the inflammatory response
Semaglutide 2.4 mg hits 12 to 15 percent mean loss by 68 to 104 weeks in STEP programs
264 The cardiovascular outcome trial for tirzepatide (SURPASS-CVOT) has demonstrated cardiovascular benefit in people with type 2 diabetes and atherosclerotic CVD
Note the time you took the dose and wait at least an hour before deciding if it was effective, accounting for slower digestion
Additionally, both drug classes exert favourable effects on body weightGLP-1 receptor agonists through appetite suppression and delayed gastric emptying, SGLT2 inhibitors through caloric loss via glycosuria